KamadaAktie

ISIN: IL0010941198 | WKN: A0JMEX | Symbol: KMDA
8,360
 
USD
30.09.20 Nasdaq
+4,24 %
+0,340 USD
Geldkurs 30.09.20
8,320 USD
3.900 Stk.
Briefkurs 30.09.20
8,370 USD
900 Stk.
Mehr Daten anzeigen
Smartbroker
NewsFlashAnzeige
Hot Stock! Explosiv: Aktie mit großem Anlauf! Modern Meat wirbelt nicht nur mit Produkten alles auf…

Kamada Chart

Neuigkeiten zur Kamada Ltd Aktie

ZeitTitel
SmartbrokerJetzt auf smartbroker.de - ab 0 € pro Order handeln! Anzeige
08.09.20
Kamada Announces Completion of Enrollment and Initial Interim Results from its Phase 1/2 Clinical Trial in Israel of its Plasma-Derived Hyperimmune Immunoglobulin (IgG) Product as a Potential Treatment for Coronavirus Disease (COVID-19)
19.08.20
Kamada and Kedrion Biopharma Announce Results of First and Only U.S. Post-Marketing Pediatric Trial of a Human Rabies Immune Globulin (HRIG); The Study Met Its Primary Objective
12.08.20
Kamada Announces Changes to its Board of Directors
12.08.20
Kamada Reports Second Quarter and First Six Months of 2020 Financial Results, Recent Corporate Achievements and Strong Cash Position  
10.08.20
Kamada Announces Enrollment of First Patient in its Phase 1/2 Clinical Trial of its Plasma-Derived Immunoglobulin (IgG) Product as a Potential Treatment for Coronavirus Disease (COVID-19) in Israel
05.08.20
Kamada to Announce Second Quarter Ended June 30, 2020 Financial Results and Host Conference Call on August 12, 2020
17.06.20
Kamada Announces Availability of its Plasma-Derived Hyperimmune IgG Therapy for Coronavirus Disease (COVID-19) for Compassionate Use Treatment in Israel
18.05.20
Kamada Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Progress
11.05.20
Kamada to Announce First Quarter Ended March 31, 2020 Financial Results and Host Conference Call on May 18, 2020
27.04.20
Kamada and Kedrion Biopharma Announce Global Collaboration for the Development, Manufacturing and Distribution of a Plasma-Derived Anti-SARS-CoV-2 (COVID-19) Polyclonal Immunoglobulin Product
11.03.20
Kamada Provides Update on Progress Related to its Proprietary Hyper-Immunoglobulin (IgGs) Platform Technology including its Commercial Anti-Rabies IgG and its Pipeline Products Anti-Corona (COVID-19) and Anti-Zika IgGs
26.02.20
Kamada Files Annual Report for the Year Ended December 31, 2019
12.02.20
Kamada Reports Financial Results for Fourth Quarter and Fiscal Year 2019
05.02.20
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2019 Financial Results and Host Conference Call on February 12, 2020
21.01.20
Kamada Announces $25 Million Private Placement with FIMI Opportunity Fund
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Nachrichten aus der Branche Chemie

ZeitTitel
30.09.20
Advanced Emissions Solutions, Inc. Announces 15-Year Activated Carbon Supply Agreement with Cabot Corporation
30.09.20
Cabot Corporation Announces Long-Term Supply Agreement With ADES
30.09.20
Gear4 Introduces Protective Cases for New Google Pixel 4a 5G and Pixel 5 Phones
30.09.20
InvisibleShield Introduces Glass Screen Protection for the Google Pixel 4a 5G and Pixel 5 Smartphones
30.09.20
AKTIE IM FOKUS: Bayer-Aktien nachbörslich im Rückwärtsgang
mehr Branchennachrichten »

Aktienkurs Kamada A0JMEX | IL0010941198

BörsenplatzNasdaq
Letzter Kurs8,360USD
Performance+4,24 %
Kurszeit30.09.20
Eröffnung8,200USD
Tageshoch8,770USD
Tagestief8,200USD
Vortageskurs8,020USD
Volumen290,75 Tsd.Stk.
52-Wochen Hoch13,330USD
52-Wochen Tief4,400USD
Anzahl Trades1.207
Performance 1 Monat-20,35 %
Performance 1 Jahr+57,45 %

Stammdaten zu Kamada

NameKamada Ltd
KurznameKamada
NamenszusatzBearer Shs
KategorieAktien
AktientypStammaktien
WKNA0JMEX
ISINIL0010941198
SymbolKMDA
BrancheChemie
LandIsrael Israel
ReferenzwährungILS
Aktienanzahl36,42 Mio.
Marktkapitalisierung304,46 Mio.USD

Performance Kamada Aktie

ZeitKursPerf.
1 Tag8,360USD
+4,24 %
1 Woche8,690USD
-6,33 %
1 Monat10,220USD
-20,35 %
3 Monate7,670USD
+6,13 %
6 Monate5,490USD
+48,27 %
Lfd. Jahr6,830USD
+19,18 %
1 Jahr5,170USD
+57,45 %
3 Jahre4,800USD
+69,58 %
5 Jahre3,380USD
+140,83 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameKamada Ltd
StadtRehovot
LandIsrael Israel
Webseitewww.kamada.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Edap TMS
-0,86
2.
Addex Therapeutics
+0,40
3.
Formycon
-1,80
4.
AEterna Zentaris
-2,50
5.
Biolife Solutions
+0,98
6.
Sage Therapeutics
+2,43
7.
Prescient Therapeutics
-2,78
8.
Zenosense
+5,26
9.
MannKind
-1,57
10.
Titan Medical
-1,36

Emissionsinformationen

Emissionspreis9,250USD
Emissionsvolumen5.582.636Stück
ZeichnungsgebührNein
IPO Anmeldetag15.05.2013
IPO31.05.2013